Astria Therapeutics, Inc. logo

Astria Therapeutics, Inc.

NASDAQ:ATXS

Overview | Financials
Company Name Astria Therapeutics, Inc.
Symbol ATXS
Currency USD
Price 11.12
Market Cap 627,449,336
Dividend Yield 0%
52-week-range 4.26 - 16.9
Industry Biotechnology
Sector Healthcare
CEO Ms. Jill C. Milne Ph.D.
Website https://www.astriatx.com

An error occurred while fetching data.

About Astria Therapeutics, Inc.

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of

Related Stocks

Zynerba Pharmaceuticals, Inc. logo

Zynerba Pharmaceuticals, Inc.

ZYNE

1.3 USD

Acasti Pharma Inc. logo

Acasti Pharma Inc.

ACST

2.41 USD

NexImmune, Inc. logo

NexImmune, Inc.

NEXI

0.371 USD

Aquestive Therapeutics, Inc. logo

Aquestive Therapeutics, Inc.

AQST

4.18 USD

Ocuphire Pharma, Inc. logo

Ocuphire Pharma, Inc.

OCUP

1.2 USD

Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc.

ELDN

2.54 USD

Eargo, Inc. logo

Eargo, Inc.

EAR

2.57 USD

Financials

Numbers are in millions USD

Numbers are in millions USD